US2014100649A1PendingUtilityA1

Method of fabricating a low crystallinity poly(l-lactide) tube

Assignee: ABBOTT CARDIOVASCULAR SYSTEMSPriority: Aug 28, 2009Filed: Sep 30, 2013Published: Apr 10, 2014
Est. expiryAug 28, 2029(~3.1 yrs left)· nominal 20-yr term from priority
B29C 48/70B29C 48/09B29C 48/34B29L 2031/7542A61L 31/14A61F 2210/0004A61L 31/06A61F 2/82B29C 48/395B29C 48/08B29C 48/05B29C 48/10B29C 48/131
57
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Methods of fabricating a low crystallinity polymer tube for polymers subject to strain-induced crystallization. The low crystallinity tube may be further processed to make an implantable medical device.

Claims

exact text as granted — not AI-modified
1 - 20 . (canceled) 
     
     
         21 . A stent comprising:
 a cylindrically-shaped scaffold including a biodegradable polymer having a pattern of a plurality of interconnecting struts formed from a polymeric tube comprising the biodegradable polymer, wherein the biodegradable polymer of the polymer tube has a crystallinity of 20% to 50 the crystallinity comprises crystals of a spherulite form and a shish-kebob form with less than 5% of the crystals being of the spherulite form, wherein the stent is expandable within an anatomical lumen of a body.   
     
     
         22 . The stent of  claim 21 , wherein 15% to 45% of the crystallinity is of the shish-kebob form. 
     
     
         23 . The stent of  claim 21 , wherein the biodegradable polymer of the polymer tube comprises a crystallinity of 30% to 45%. 
     
     
         24 . The stent of  claim 21 , wherein 25% to 40% of the crystallinity is of the shish-kebob form. 
     
     
         25 . The stent of  claim 21 , wherein the polymer comprises poly(L-lactide). 
     
     
         26 . The stent of  claim 21 , wherein the polymer comprises poly(L-lactide-co-glycolide). 
     
     
         27 . The stent of  claim 26 , wherein the poly(L-lactide-co-glycolide) is 15 mol % L-lactide and 85% glycolide. 
     
     
         28 . The stent of  claim 21 , wherein the polymer comprises poly(L-lactide-co-caprolactone). 
     
     
         29 . The stent of  claim 21 , wherein the pattern is formed by cutting the pattern in the polymer tube.

Join the waitlist — get patent alerts

Track US2014100649A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.